BEAM
Price
$25.96
Change
+$0.17 (+0.66%)
Updated
Oct 17, 04:59 PM (EDT)
Capitalization
2.61B
24 days until earnings call
FBLG
Price
$0.40
Change
-$0.01 (-2.44%)
Updated
Oct 17, 04:59 PM (EDT)
Capitalization
17.17M
32 days until earnings call
Interact to see
Advertisement

BEAM vs FBLG

Header iconBEAM vs FBLG Comparison
Open Charts BEAM vs FBLGBanner chart's image
Beam Therapeutics
Price$25.96
Change+$0.17 (+0.66%)
Volume$22.27K
Capitalization2.61B
FibroBiologics
Price$0.40
Change-$0.01 (-2.44%)
Volume$22.91K
Capitalization17.17M
BEAM vs FBLG Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. FBLG commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and FBLG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (BEAM: $25.79 vs. FBLG: $0.41)
Brand notoriety: BEAM and FBLG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 88% vs. FBLG: 250%
Market capitalization -- BEAM: $2.63B vs. FBLG: $16.79M
BEAM [@Biotechnology] is valued at $2.63B. FBLG’s [@Biotechnology] market capitalization is $16.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileFBLG’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • FBLG’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than FBLG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 2 TA indicator(s) are bullish while FBLG’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 2 bullish, 5 bearish.
  • FBLG’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both BEAM and FBLG are a bad buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -7.46% price change this week, while FBLG (@Biotechnology) price change was -15.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +16.02%, and the average quarterly price growth was +79.42%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

FBLG is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.61B) has a higher market cap than FBLG($17.2M). BEAM YTD gains are higher at: 3.992 vs. FBLG (-79.500). FBLG has higher annual earnings (EBITDA): -12.55M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. FBLG (8.85M). FBLG has less debt than BEAM: FBLG (10.8M) vs BEAM (155M). BEAM has higher revenues than FBLG: BEAM (60.3M) vs FBLG (0).
BEAMFBLGBEAM / FBLG
Capitalization2.61B17.2M15,169%
EBITDA-414.33M-12.55M3,302%
Gain YTD3.992-79.500-5%
P/E RatioN/AN/A-
Revenue60.3M0-
Total Cash1.15B8.85M13,002%
Total Debt155M10.8M1,435%
TECHNICAL ANALYSIS
Technical Analysis
BEAMFBLG
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBLG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CEMIX14.230.09
+0.64%
Causeway Emerging Markets Instl
GSJPX43.10-0.15
-0.35%
Goldman Sachs Technology Opps P
VAFCX26.29-0.11
-0.42%
Invesco American Franchise C
CAMWX29.16-0.19
-0.65%
Cambiar Opportunity Inst
SUFCX38.69-0.47
-1.20%
NAA Mid Growth C

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-5.15%
CRSP - BEAM
66%
Closely correlated
-4.72%
NTLA - BEAM
63%
Loosely correlated
-3.93%
RXRX - BEAM
61%
Loosely correlated
-6.33%
AXON - BEAM
57%
Loosely correlated
+1.11%
PRME - BEAM
56%
Loosely correlated
-8.95%
More

FBLG and

Correlation & Price change

A.I.dvisor tells us that FBLG and XNCR have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FBLG and XNCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBLG
1D Price
Change %
FBLG100%
-8.89%
XNCR - FBLG
33%
Poorly correlated
+6.03%
VYGR - FBLG
33%
Poorly correlated
+0.76%
OCUL - FBLG
32%
Poorly correlated
+2.22%
IPSC - FBLG
32%
Poorly correlated
-2.25%
BEAM - FBLG
32%
Poorly correlated
-5.15%
More